Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: G. Ralph Corey, MD
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 4 ans
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
The purpose of this Phase 3 trial is to evaluate the efficacy, safety, and tolerability of oritavancin in ABSSSIs, including those caused by MRSA and to evaluate the potential economic ben...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 5 ans
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
Study 0019 (NCT00124020) compares the safety and effectiveness of an investigational drug, telavancin, with vancomycin for the treatment of hospital-acquired pneumonia.
Country
Israel
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 5 ans
Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
Study 0017 compares the safety and effectiveness of an investigational drug, telavancin, and an approved drug, vancomycin, for the treatment of complicated skin and skin structure infectio...
Country
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 4 ans
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
The purpose of this Phase 3 trial is to evaluate the efficacy, safety, and tolerability of oritavancin in ABSSSIs, including those caused by MRSA and to evaluate the potential economic ben...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 4 ans
Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia
The purpose of this study is to determine whether telavancin (TD-6424, ARBELIC) can be safety administered to patients with bloodstream infections and whether telavancin is effective in tr...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 4 ans
Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Serious infections caused by resistant bacteria are becoming more of a medical problem throughout the world. This study will measure how well TD-6424 (Telavancin) can control infections an...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 4 ans
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Serious infections caused by resistant bacteria are becoming more of a medical problem throughout the world. One of the ways to deal with this problem is to develop new drugs that can cont...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 5 ans
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
Study 0015 (NCT00107952) compares the safety and effectiveness of an investigational drug, telavancin, with vancomycin for the treatment of hospital-acquired pneumonia.
Country
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
G. Ralph Corey, MD
Update Il y a 5 ans
Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
Study 0018 (NCT00107978) compares the safety and effectiveness of an investigational drug, telavancin, and an approved drug, vancomycin, for the treatment of complicated skin and skin stru...
Country
United States
organs
None
Specialty
None
Closed trial
More information